We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $71.3B
1-Year Est. Return 56.8%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,067.32%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
126
DexCom
DXCM
$33.8B
$105M 0.16%
1,666,408
+78,858
+5% +$5.49M
ACN icon
127
Accenture
ACN
$108B
$104M 0.16%
526,222
-8,600
-2% -$2M
ADI icon
128
Analog Devices
ADI
$187B
$104M 0.16%
327,737
-53,677
-14% -$17.1M
INTU icon
129
Intuit
INTU
$94.9B
$103M 0.16%
239,300
-2,400
-1% -$1.14M
VOYA icon
130
Voya Financial
VOYA
$9.14B
$102M 0.16%
+1,500,000
New +$109M
C icon
131
Citigroup
C
$233B
$102M 0.16%
895,486
-503,700
-36% -$57.4M
PGR icon
132
Progressive
PGR
$122B
$101M 0.16%
510,085
+85,100
+20% +$17.6M
COR icon
133
Cencora
COR
$59.4B
$100M 0.15%
318,962
+125,462
+65% +$43.8M
TT icon
134
Trane Technologies
TT
$105B
$100M 0.15%
240,235
+78,677
+49% +$33.4M
MO icon
135
Altria Group
MO
$110B
$99.2M 0.15%
1,503,832
-13,400
-0.9% -$862K
AXP icon
136
American Express
AXP
$231B
$98.7M 0.15%
326,288
-55,300
-14% -$18.5M
TRV icon
137
Travelers Companies
TRV
$77.3B
$97.8M 0.15%
335,304
+7,300
+2% +$2.14M
GPOR icon
138
Gulfport Energy Corp
GPOR
$3B
$97.3M 0.15%
460,059
+13,832
+3% +$2.75M
MDGL icon
139
Madrigal Pharmaceuticals
MDGL
$11.7B
$97M 0.15%
185,331
+162,105
+698% +$77.4M
APP icon
140
Applovin
APP
$106B
$96.6M 0.15%
242,800
-1,600
-0.7% -$773K
AEP icon
141
American Electric Power
AEP
$68.5B
$95.6M 0.15%
+729,506
New +$91.3M
AWI icon
142
Armstrong World Industries
AWI
$7.66B
$94.8M 0.15%
575,000
+287,000
+100% +$52.5M
IDYA icon
143
IDEAYA Biosciences
IDYA
$3.5B
$94.1M 0.15%
2,823,500
+23,500
+0.8% +$788K
FBIN icon
144
Fortune Brands Innovations
FBIN
$5.7B
$93.8M 0.14%
2,407,536
+1,351,536
+128% +$70.3M
ULTA icon
145
Ulta Beauty
ULTA
$22B
$92.4M 0.14%
176,752
+118,300
+202% +$75.2M
HON icon
146
Honeywell
HON
$74.1B
$92.3M 0.14%
408,451
-19,966
-5% -$4.56M
CI icon
147
Cigna
CI
$74.3B
$92.2M 0.14%
345,671
-92,480
-21% -$25.6M
NOW icon
148
ServiceNow
NOW
$129B
$91.7M 0.14%
877,100
-14,800
-2% -$1.74M
DE icon
149
Deere & Co
DE
$165B
$91.6M 0.14%
162,564
-18,550
-10% -$10.5M
NEM icon
150
Newmont
NEM
$124B
$90.7M 0.14%
837,600
-8,700
-1% -$1M
4 5
6
7 8

Similar funds

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.